english.prescrire.org > Spotlight > Archives : 2016 > In the April issue of Prescrire International: adverse effects of SSRIs, gliptins and mirabegron

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2016 : 1 | 30 | 60

In the April issue of Prescrire International: adverse effects of SSRIs, gliptins and mirabegron

FREE DOWNLOAD In this sample page from the Adverse Effects section of the April issue: extrapyramidal reactions with certain antidepressants, joint pain with gliptins and the cardiovascular effects of incontinence drug mirabegron.
Full text available for free download.

SSRI antidepressants: extrapyramidal reactions

  • If tremor, dystonia or abnormal movements develop in a patient taking a serotonergic antidepressant, the role of the drug must be suspected and its discontinuation suggested

Gliptins: disabling joint pain

  • If a gliptin-treated patient develops joint pain, recognising the drug’s role and stopping this treatment can relieve the pain and avoid exposure to antirheumatic or anti-inflammatory drugs and to their adverse effects

Mirabegron: hypertension, stroke

  • Mirabegron has been implicated in cases of severe hypertension and hypertensive crisis associated with cardiovascular disorders, including stroke

Full text available for free download.

 ©Prescrire 1 April 2016

Prescrire Int 2016; 25 (170): 100. (Pdf, free)
Download the full review
Pdf, free